Cargando…
Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Cancerous inhibitor of protein phosphatase 2A (CIP2A), an endogenous protein phosphatase 2A (PP2A) inhibitor, has been identified as an oncoprotein in promoting cancer initiation and progression of several types of cancer. However, the expression and the role played by CIP2A in the pathogenesis of m...
Autores principales: | Liu, Xuewen, Cao, Wei, Qin, Shanshan, Zhang, Te, Zheng, Junnian, Dong, Ying, Ming, Pinghong, Cheng, Qian, Lu, Zheng, Guo, Yang, Zhang, Baofu, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661621/ https://www.ncbi.nlm.nih.gov/pubmed/29263916 http://dx.doi.org/10.1038/sigtrans.2017.13 |
Ejemplares similares
-
High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019) -
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
por: Pawlyn, C, et al.
Publicado: (2017) -
CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014) -
Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer
por: Ma, Liang, et al.
Publicado: (2011) -
High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)